Ethnic disparities in the epidemiology, treatment, and outcome of patients with hepatocellular carcinoma in the United States
Authors:
Open Access
- 1 January 2023
- journal article
- editorial
- Published by OAE Publishing Inc. in Hepatoma Research
- Vol. 9
Abstract
Various HCC etiology, tumor biology, host genetics, and socioeconomic factors among different ethnicities likely contribute to the variation in curative treatment receipt and outcome.Keywords
This publication has 55 references indexed in Scilit:
- Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative TherapiesJournal of Clinical Gastroenterology, 2016
- Population attributable fractions of risk factors for hepatocellular carcinoma in the United StatesCancer, 2016
- Disparity in liver cancer incidence and chronic liver disease mortality by nativity in Hispanics: The Multiethnic CohortCancer, 2016
- Liver Cancer: Connections with Obesity, Fatty Liver, and CirrhosisAnnual Review of Medicine, 2016
- Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: Results from the surveillance, epidemiology, and end results registryLiver Transplantation, 2014
- Meta-analysis: underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United StatesAlimentary Pharmacology & Therapeutics, 2013
- Predictors of Surgical Intervention for Hepatocellular CarcinomaArchives of Surgery, 2011
- The Prevalence of Hepatitis B Virus Infection in the United States in the Era of VaccinationThe Journal of Infectious Diseases, 2010
- Approaching Health Disparities From a Population Perspective: The National Institutes of Health Centers for Population Health and Health DisparitiesAmerican Journal of Public Health, 2008
- The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004Cancer, 2007